Plasminogen activator inhibitor type 2 gene induction by tumor necrosis factor and phorbol ester involves transcriptional and post-transcriptional events. Identification of a functional nonameric AU-rich motif in the 3'-untranslated region

J Biol Chem. 1996 Oct 18;271(42):26074-80. doi: 10.1074/jbc.271.42.26074.

Abstract

Plasminogen activator inhibitor type 2 (PAI-2) mRNA and antigen levels are synergistically induced in HT-1080 fibrosarcoma cells when treated with a combination of tumor necrosis factor (TNF) and phorbol 12-myristate 13-acetate (PMA). Here we demonstrate that this effect is not fully reflected at the level of gene transcription, suggesting a contribution of post-transcriptional events in this induction. Insertion of the 3'-untranslated region (3'-UTR) of PAI-2 mRNA into the 3'-UTR of a rabbit beta-globin reporter gene reduces beta-globin-PAI-2 chimeric mRNA expression in stably transfected cells. The region within the PAI-2 3'-UTR responsible for this effect is located within the 368-nucleotide sequence preceding the poly(A) tail, a segment that includes a nonameric UUAUUUAUU motif. Mutagenesis of this element abolishes the PAI-2 3'-UTR destabilizing effect, revealing a functional role for this motif. TNF and PMA co-treatment of transfected cells increases beta-globin-PAI-2 chimeric mRNA expression 3-4-fold, indicating that the inherently unstable 3'-UTR of PAI-2 mRNA can become stabilized in response to TNF and PMA. Our results indicate that induction of PAI-2 gene expression by TNF and PMA involves both direct transcription as well as mRNA stabilization, the latter involving an AU-rich nonameric motif in the 3'-UTR.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blotting, Northern
  • Cell Line
  • DNA Primers / metabolism
  • Drug Synergism
  • Electrophoresis, Agar Gel
  • Fibrosarcoma / metabolism
  • Gene Expression Regulation / drug effects*
  • Globins / genetics
  • Humans
  • Nucleic Acid Conformation
  • Plasminogen Activator Inhibitor 2 / genetics*
  • Polymerase Chain Reaction
  • Protein Processing, Post-Translational / drug effects*
  • RNA, Messenger / metabolism
  • Rabbits
  • Tetradecanoylphorbol Acetate / pharmacology*
  • Transcription, Genetic / drug effects*
  • Transcriptional Activation
  • Tumor Necrosis Factor-alpha / pharmacology*

Substances

  • DNA Primers
  • Plasminogen Activator Inhibitor 2
  • RNA, Messenger
  • Tumor Necrosis Factor-alpha
  • Globins
  • Tetradecanoylphorbol Acetate